116 related articles for article (PubMed ID: 33411866)
1. Fucosyltransferase-specific inhibition via next generation of fucose mimetics.
Martin KC; Tricomi J; Corzana F; García-García A; Ceballos-Laita L; Hicks T; Monaco S; Angulo J; Hurtado-Guerrero R; Richichi B; Sackstein R
Chem Commun (Camb); 2021 Jan; 57(9):1145-1148. PubMed ID: 33411866
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Fluorinated l-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells.
Dai Y; Hartke R; Li C; Yang Q; Liu JO; Wang LX
ACS Chem Biol; 2020 Oct; 15(10):2662-2672. PubMed ID: 32930566
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
4. Differential Labeling of Glycoproteins with Alkynyl Fucose Analogs.
Ma C; Takeuchi H; Hao H; Yonekawa C; Nakajima K; Nagae M; Okajima T; Haltiwanger RS; Kizuka Y
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825463
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of human alpha-1,3-fucosyltransferase V: glycosidic cleavage occurs prior to nucleophilic attack.
Murray BW; Wittmann V; Burkart MD; Hung SC; Wong CH
Biochemistry; 1997 Jan; 36(4):823-31. PubMed ID: 9020780
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of transition-state analogue inhibitors of alpha-1,3-fucosyltransferase.
Mitchell ML; Tian F; Lee LV; Wong CH
Angew Chem Int Ed Engl; 2002 Aug; 41(16):3041-4. PubMed ID: 12203452
[No Abstract] [Full Text] [Related]
7. Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.
Zandberg WF; Kumarasamy J; Pinto BM; Vocadlo DJ
J Biol Chem; 2012 Nov; 287(47):40021-30. PubMed ID: 23019334
[TBL] [Abstract][Full Text] [Related]
8. Development of orally active inhibitors of protein and cellular fucosylation.
Okeley NM; Alley SC; Anderson ME; Boursalian TE; Burke PJ; Emmerton KM; Jeffrey SC; Klussman K; Law CL; Sussman D; Toki BE; Westendorf L; Zeng W; Zhang X; Benjamin DR; Senter PD
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5404-9. PubMed ID: 23493549
[TBL] [Abstract][Full Text] [Related]
9. The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.
Keeley T; Lin S; Lester DK; Lau EK; Yang S
PLoS One; 2018; 13(6):e0199128. PubMed ID: 29924834
[TBL] [Abstract][Full Text] [Related]
10. Expression of fucosylated antigens and alpha 1,3 fucosyltransferases in human leukaemia cell lines.
Robinson NE; de Vries T; Davis RE; Stults CL; Watson SR; van den Eijnden DH; Macher BA
Glycobiology; 1994 Jun; 4(3):317-26. PubMed ID: 7949657
[TBL] [Abstract][Full Text] [Related]
11. Chemo-enzymatic synthesis of fluorinated sugar nucleotide: useful mechanistic probes for glycosyltransferases.
Burkart MD; Vincent SP; Düffels A; Murray BW; Ley SV; Wong CH
Bioorg Med Chem; 2000 Aug; 8(8):1937-46. PubMed ID: 11003139
[TBL] [Abstract][Full Text] [Related]
12. Using Eukaryotic Expression Systems to Generate Human α1,3-Fucosyltransferases That Effectively Create Selectin-Binding Glycans on Stem Cells.
Al-Amoodi AS; Sakashita K; Ali AJ; Zhou R; Lee JM; Tehseen M; Li M; Belmonte JCI; Kusakabe T; Merzaban JS
Biochemistry; 2020 Oct; 59(39):3757-3771. PubMed ID: 32901486
[TBL] [Abstract][Full Text] [Related]
13. Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells.
Dykstra B; Lee J; Mortensen LJ; Yu H; Wu ZL; Lin CP; Rossi DJ; Sackstein R
Stem Cells; 2016 Oct; 34(10):2501-2511. PubMed ID: 27335219
[TBL] [Abstract][Full Text] [Related]
14. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
15. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
Pachón-Peña G; Donnelly C; Ruiz-Cañada C; Katz A; Fernández-Veledo S; Vendrell J; Sackstein R
Stem Cells; 2017 Apr; 35(4):1080-1092. PubMed ID: 27888602
[TBL] [Abstract][Full Text] [Related]
16. Participation of an endogenous inhibitor of fucosyltransferase activities in the developmental regulation of intestinal fucosylation processes.
Ruggiero-Lopez D; Biol MC; Louisot P; Martin A
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):801-6. PubMed ID: 1953674
[TBL] [Abstract][Full Text] [Related]
17. Delineation of fucosyltransferase activities with thiol reagents.
Kessel D; Chou TH
Biochem J; 1979 Sep; 181(3):767-9. PubMed ID: 518555
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of GDP-fucose:nLcOse4Cer alpha 1----3-fucosyltransferase from human small cell lung carcinoma NCI-H69 cells with the GDP-fucose analog GDP-hexanolaminyl-4-azidosalicylic acid.
Holmes EH
J Biol Chem; 1990 Aug; 265(22):13150-6. PubMed ID: 2165495
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression of GDP-L-fucose-synthesizing enzymes, GDP-fucose transporter and fucosyltransferase VII.
Niittymäki J; Mattila P; Renkonen R
APMIS; 2006; 114(7-8):539-48. PubMed ID: 16907860
[TBL] [Abstract][Full Text] [Related]
20. Development of α1,6-fucosyltransferase inhibitors through the diversity-oriented syntheses of GDP-fucose mimics using the coupling between alkyne and sulfonyl azide.
Manabe Y; Kasahara S; Takakura Y; Yang X; Takamatsu S; Kamada Y; Miyoshi E; Yoshidome D; Fukase K
Bioorg Med Chem; 2017 Jun; 25(11):2844-2850. PubMed ID: 28284868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
